Structure of cytotoxic amyloid oligomers generated during disaggregation

Toshisuke Kaku1, Kazunori Ikebukuro1, Kaori Tsukakoshi1

  • 1Department of Biotechnology and Life Science, Tokyo University of Agriculture and Technology, 2-24-16 Naka-cho, Koganei, Tokyo 184-8588, Japan.

PubMed

Insights

Cytotoxic amyloid oligomers, implicated in disease, can form during fibril disaggregation. These toxic species exhibit fibrous structures and metastability, offering new therapeutic targets.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Structural Biology

Background:

  • Amyloidosis involves abnormal amyloid protein accumulation.
  • Intermediate amyloid oligomers are key toxins.
  • Oligomers form via aggregation and fibril disaggregation.

Purpose of the Study:

  • To summarize structural commonalities of cytotoxic oligomers formed during disaggregation.
  • To investigate the generation conditions of these toxic oligomers.
  • To provide insights for developing drugs targeting amyloid aggregates.

Main Methods:

  • Literature review of cytotoxic oligomer formation.
  • In vitro experiments with heat shock proteins and small compounds.
  • Molecular dynamics simulations of oligomer structures.

Main Results:

  • High-molecular-weight oligomers (protofibrils/protofilaments) with fibrous morphology and β-sheet structure were identified.
  • Distorted β-sheet structures contribute to oligomer metastability.
  • Cytotoxic oligomers form during early stages of disaggregation under mild conditions.

Conclusions:

  • Understanding cytotoxic oligomer characteristics is crucial for amyloidosis research.
  • Targeting these specific oligomers may lead to novel therapeutic strategies.
  • This review aids in exploring and developing drugs against toxic amyloid aggregates.